HomeV30 • FRA
add
Apotea Sverige AB
Previous close
€8.55
Day range
€8.74 - €8.86
Year range
€6.00 - €9.40
Market cap
9.86B SEK
Avg Volume
54.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.75B | 15.23% |
Operating expense | 392.50M | 11.19% |
Net income | 71.60M | 47.02% |
Net profit margin | 4.08 | 27.50% |
Earnings per share | — | — |
EBITDA | 112.18M | 40.31% |
Effective tax rate | 20.58% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.80M | 8.90% |
Total assets | 1.92B | — |
Total liabilities | 1.22B | — |
Total equity | 706.90M | — |
Shares outstanding | 104.07M | — |
Price to book | 1.30 | — |
Return on assets | 13.01% | — |
Return on capital | 23.38% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 71.60M | 47.02% |
Cash from operations | 123.20M | 57.14% |
Cash from investing | -116.70M | -683.22% |
Cash from financing | -13.10M | 81.26% |
Net change in cash | -6.50M | -1.56% |
Free cash flow | -1.98M | — |
About
CEO
Founded
2003
Website
Employees
727
